Atezolizumab: Solution concentrate for I.V. infusion 840 mg in 14 mL; Tecentriq® Page last updated: 2 July 2021 Public Summary Document (PSD) March 2021 PBAC Meeting - (PDF 1686KB) Public Summary Document (PSD) March 2021 PBAC Meeting - (Word 688KB)